Lausanne, Switzerland, May 5, 2020 – Galderma today announced the closing of the sale of Bübchen to Dallmann’s Pharma GmbH, a company of Katjes International GmbH & Co. KG.
Galderma will present data from across its Therapeutic Dermatology portfolio at the XIV International Congress of Dermatology (ICD), taking place in Rome, Italy, on June 18-21, 2025, including updates on its investigations in acne, non-melanoma skin cancer, and prurigo nodularis.
Results 31 - 35 of 155
Page 7 of 31
Confirm navigation
You are about to leave the Galderma global site. Are you sure you want to leave this page?
